Within the AME, we detected a high expression of RARRES2, a key modulator of tumour growth and inflammation, in line with a previous study reporting a higher RARRES2 expression in benign compared to malignant adrenocortical tumours.84 Here, RARRES2 is linked to adrenal cortex neoplasm.